3,4-dihydroxyphenylacetic acid has been researched along with kampirone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Moal, M; Louilot, A; Simon, H | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and kampirone
| Article | Year |
|---|---|
A study of the effects of buspirone, BMY 13805, and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Buspirone; Dopamine; Electrochemistry; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Nucleus Accumbens; Piperazines; Pyrimidines; Rats; Rats, Inbred Strains; Septal Nuclei | 1986 |